| 000 | 01648 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513150216.0 | ||
| 264 | 0 | _c19981027 | |
| 008 | 199810s 0 0 pol d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChybicka, A | |
| 245 | 0 | 0 |
_a[Treatment outcome for myelodysplastic syndromes (MDS) obtained by the Polish Children's Leukemia/Lymphoma Study Group]. _h[electronic resource] |
| 260 |
_bPolskie Archiwum Medycyny Wewnetrznej _cFeb 1998 |
||
| 300 |
_a155-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMercaptopurine _xadministration & dosage |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xtherapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aValproic Acid _xadministration & dosage |
| 700 | 1 | _aKołecki, P | |
| 700 | 1 | _aPietras, W | |
| 700 | 1 | _aBogusławska-Jaworska, J | |
| 700 | 1 | _aWójcik, D | |
| 700 | 1 | _aArmata, J | |
| 700 | 1 | _aEliasińska, A | |
| 700 | 1 | _aKowalczyk, J | |
| 700 | 1 | _aJackowska, T | |
| 700 | 1 | _aKlus, K | |
| 700 | 1 | _aMatysiak, M | |
| 700 | 1 | _aKrauze, A | |
| 700 | 1 | _aStefańska, K | |
| 700 | 1 | _aRokicka-Milewska, R | |
| 700 | 1 | _aWiśniewska-Slusarz, H | |
| 773 | 0 |
_tPolskie Archiwum Medycyny Wewnetrznej _gvol. 99 _gno. 2 _gp. 155-8 |
|
| 999 |
_c9652220 _d9652220 |
||